Octatropine-methyl-bromide and sulglycotide salt in the short-term treatment of active duodenal ulcer. A double blind endoscopic study of 40 outpatients.
G Dobrilla, M Valentini, M C Bonoldi, L Piazzi
Index: Scand. J. Gastroenterol. Suppl. 167 , 65-7, (1989)
Full Text: HTML
Abstract
Forty outpatients with endoscopically confirmed duodenal ulcers were entered in a double blind trial. They were randomly allocated to octatropine-methyl-bromide and sulglycotide salt (GVP) or placebo. The results show that the combination of the two drugs is less efficacious than the two constituent substances taken separately, is not more efficacious than placebo in ulcer healing, and is ineffective with regard to ulcer pain.
Related Compounds
Related Articles:
[Pediatric use of a drug, anticholinergic and muscle relaxant on the gastrointestinal tract].
1982-01-01
[Pediatr. Med. Chir. 4(1-2) , 79-81, (1982)]
1982-09-30
[ZFA (Stuttgart.) 58(27) , 1481-4, (1982)]
[Preliminary clinical research on a new anti-ulcer drug].
1979-05-31
[Clin. Ter. 89(4) , 365-71, (1979)]
1980-04-01
[Pharmacol. Res. Commun. 12(4) , 307-17, (1980)]